Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword

Jie Wang1,2, Ning Liu2, Hongfei Jiang1,2

  • 1The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.

Insights

Reactive oxygen species (ROS) are crucial for immunity, but their complex roles in cancer immunotherapy require careful consideration. Modulating ROS levels offers potential but needs precise control for optimal therapeutic outcomes.

Area of Science:

  • Immunology
  • Biochemistry
  • Cancer Research

Background:

  • Reactive oxygen species (ROS) are vital mediators in immune responses, including innate and adaptive immunity.
  • Modulating ROS levels presents a promising strategy for enhancing anticancer immunity.
  • Understanding the multifaceted roles of ROS, which vary by concentration, location, and microenvironment, is crucial.

Purpose of the Study:

  • To review the diverse effects of ROS on key components of the anticancer immune response.
  • To evaluate the potential and challenges of targeting ROS in cancer immunotherapy.
  • To highlight the need for advanced technologies for precise ROS modulation.

Main Methods:

  • Literature review of studies investigating ROS effects on macrophage polarization.
  • Analysis of ROS impact on immune checkpoint blocking (ICB) therapy efficacy.
  • Examination of ROS roles in T cell activation, expansion, and immunogenic cell death induction.

Main Results:

  • ROS exhibit pleiotropic effects, often detrimental, but not always amenable to simple scavenging.
  • ROS generally have undesirable effects on T cell activation and expansion.
  • Current evidence indicates a complex, context-dependent role for ROS in cancer immunity.

Conclusions:

  • A comprehensive understanding of ROS's dual functions is essential for successful clinical application.
  • Advanced technologies for spatiotemporal and species-specific ROS tuning are necessary.
  • Integrating ROS-targeted therapies with existing immunotherapies holds significant potential for improving cancer treatment efficacy.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
723
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
4.2K
Oxygen Requirements and Growth Patterns01:29

Oxygen Requirements and Growth Patterns

Microorganisms exhibit diverse oxygen requirements and growth patterns driven by their metabolic strategies and environmental adaptations. Oxygen, while essential for many organisms, can also be toxic under certain conditions, shaping how microorganisms grow and survive.Oxygen Requirements of MicroorganismsMicroorganisms are classified based on their ability to use or tolerate oxygen:● Obligate aerobes like Mycobacterium tuberculosis need oxygen for energy production, as it serves as the...
438